Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation

Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation

ABSTRACT OBJECTIVE: To analyze the cost effectiveness of the diagnostic program for the germline mutation in BRCA1/2 genes and of preventative strategies for the relatives of patients diagnosed with ovarian cancer associated with this mutation. METHODS: The study analyzed the cost effectiveness by...

Full description

Bibliographic Details
Main Authors: Marcelo Cristiano de Azevedo Ramos, Maria Aparecida Azevedo Koike Folgueira, Simone Maistro, Alessandro Gonçalves Campolina, Patricia Coelho de Soárez, Geertruida Hendrika de Bock, Hillegonda Maria Dutilh Novaes, Maria Del Pilar Estevez Diz
Format: Article
Language:English
Published: Universidade de São Paulo 2018-11-01
Series:Revista de Saúde Pública
Subjects:
Ovarian Neoplasms, diagnosis
Genes, BRCA1
Genes, BRCA2
Early Detection of Cancer, economics
Cost-Effectiveness Evaluation
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89102018000100281&lng=en&tlng=en

Internet

http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89102018000100281&lng=en&tlng=en

Similar Items